98%
921
2 minutes
20
Due to their great environmental hazards, the widely used legacy perfluoroalkyl acids (PFAAs) are gradually restricted, and novel alternatives are being developed and applied. For efficient control of emerging environmental risks in agricultural production, we systematically studied the source apportionment in field soils and bioaccumulation characteristics in multiple crops of 12 PFAAs and five novel alternatives in an industrial-intensive region of China, followed by human exposure estimation and health risk assessment. Compared with perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), shorter-chained PFAAs and novel alternatives have become the dominant components in local soils and crops, indicating their wide application. A positive matrix factorization (PMF) model coupled with multivariate analysis identified fluoropolymer manufacturing and textile treatment as the principal sources. The bioaccumulation factors (BAFs) of individual PFAAs and alternatives in crops decreased with increasing carbon chain lengths. As a novel alternative of PFOA, hexafluoropropylene oxide dimer acid (GenX) exhibited much higher BAFs; for the alternative of PFOS, 6:2 chlorinated polyfluorinated ether sulfonic acid (6:2 Cl-PFESA) showed lower BAFs. The bioaccumulation capacities of PFAAs and alternatives were also associated with soil organic matter and crop species. Through crop consumption, short-chained PFAAs and novel alternatives might pose emerging human health threats.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jhazmat.2021.127019 | DOI Listing |
Clin Rheumatol
September 2025
Immunology Market Access, Johnson & Johnson, Horsham, PA, USA.
Introduction/objective: Oral glucocorticoids (OGC) are conventionally used as first-line treatment for dermatomyositis (DM) and polymyositis (PM). This study evaluated clinical and economic outcomes associated with long-term (LT) OGC use in DM/PM.
Methods: Adults with ≥ 2 medical claims of DM/PM 30‒365 days apart from January 1, 2016, to December 31, 2022, and ≥ 1 diagnosis code of a physician specialty of interest were selected from the MarketScan Commercial and Medicare Supplemental databases.
Cell Mol Immunol
September 2025
Department of Gastroenterology, Sir Run Run Shaw Hospital, College of Medicine Zhejiang University, Hangzhou, China.
Anti-tumor necrosis factor (TNF) therapy for inflammatory bowel disease (IBD) is hampered by issues of nonresponse and resistance, highlighting the urgent need for alternative or complementary treatments. Our study revealed significant upregulation of taurine in the intestinal tissues of IBD patients, which was inversely related to the severity of the disease. A key discovery was that TNF directly induced taurine synthesis in intestinal epithelial cells and increased the production of angiogenin, a nuclease that degrades mitochondrial RNA, which is known to amplify inflammatory responses.
View Article and Find Full Text PDFFood Chem
September 2025
Department of Pharmaceutical and Biological Engineering, School of Chemical Engineering, Sichuan University, Chengdu 610065, China. Electronic address:
Amino acid surfactants have garnered increasing attention as green and safe alternatives. Bioinspired by the melanogenesis pathway, this study developed a novel melanin-like amino acid surfactant with a melanin mimetic structure by conjugating glycine to o-quinone. Pterostilbene, a versatile natural monophenol, was oxidized to form o-quinone crystals by 2-iodoxybenzoic acid in a manner analogous to tyrosinase.
View Article and Find Full Text PDFRetina
September 2025
Department of Ophthalmology, St. Michael's Hospital/Unity Health Toronto, Toronto, Ontario, Canada.
Purpose: To report reattachment rate (RR) of pars plana vitrectomy-suprachoroidal viscopexy (VIT-SCVEXY) for rhegmatogenous retinal detachment (RRD) repair. Additionally, this study compares the anatomic reattachment rate and functional outcomes of VIT-SCVEXY vs pars plana vitrectomy with traditional scleral buckle (PPV-SB) at postoperative month 3 and final follow-up.
Methods: A retrospective cohort study conducted at St.
Clin Transl Gastroenterol
September 2025
Department of Internal Medicine, School of Medicine, University of Medicine and Pharmacy at Ho Cho Minh City, Vietnam.
Background: Severe acute pancreatitis (SAP) is a life-threatening condition requiring early risk stratification. While the Bedside Index for Severity in Acute Pancreatitis (BISAP) is widely used, its reliance on complex parameters limits its applicability in resource-constrained settings. This study introduces a decision tree model based on Classification and Regression Tree (CART) analysis, utilizing Neutrophil-to-Lymphocyte Ratio (NLR) and C-reactive Protein (CRP), as a simpler alternative for early SAP prediction.
View Article and Find Full Text PDF